Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)

Market Cap	4.10B +3.6%
Revenue (ttm)	351.25M +0.6%
Net Income	7.10M -32.8%
EPS	0.03 -29.5%
Shares Out	219.47M
PE Ratio	578.29
Forward PE	n/a
Dividend	1.20 (6.40%)
Ex-Dividend Date	Jun 12, 2025

Volume	1,330,369
Average Volume	3,411,514
Open	18.75
Previous Close	18.75
Day's Range	18.69 - 18.89
52-Week Range	16.10 - 23.28
Beta	0.33
RSI	42.97
Earnings Date	Apr 24, 2026

About SHE:002932

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents and diagnostic instruments in China. The company offers external diagnostic testing, third-party medical testing, certification consulting services, and medical information platform construction services. It also provides information software and supporting hardware products. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. was founded in 2008 and is based in Wuhan, China.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 812
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002932

Financial Performance

In 2024, SHE:002932's revenue was 350.06 million, a decrease of -53.30% compared to the previous year's 749.54 million. Earnings were 74.52 million, a decrease of -0.54%.